Demand of Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets : Technology, Applications, Growth and Status to 2022
Researchmoz added Most up-to-date research on "Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth" to its huge collection of research reports. Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. This chronic hyperglycemia is associated with long-term damage, dysfunction and failure of multiple organs, including the eyes, kidneys, nerves, heart and blood vessels. The vast majority of diabetes mellitus patients can be classified as having either Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM) . Approximately 90-95% of all diabetics have T2DM. T2DM treatment has been revolutionized in the past decade, especially with the increased use of new therapies. The marketed products landscap...